Evaluation of optical coherence tomography (OCT) changes following transretinal tumour biopsy for choroidal melanoma
- PMID: 35879448
- PMCID: PMC10050169
- DOI: 10.1038/s41433-022-02185-1
Evaluation of optical coherence tomography (OCT) changes following transretinal tumour biopsy for choroidal melanoma
Abstract
Aim: This study uses OCT imaging to examine morphological changes at the chorioretinal interface of the choroidal melanoma biopsy site over time.
Setting: Liverpool Ocular Oncology Centre (LOOC), St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom.
Methodology: Retrospective analysis of all patients who underwent 25G vitrector-assisted transretinal biopsy for choroidal melanoma between 1st Jan 2017 and 31st Dec 2019. The biopsy procedure does not involve full vitrectomy, treatment of the retinal hole or tamponade. Patients routinely undergo OCT imaging over the tumour site at each follow up. Cases required a minimum of a baseline OCT and two consecutive post-operative OCT scans of adequate quality, overlying the biopsy site. All images were reviewed and graded by an ophthalmic specialist.
Results: Fifty-one patients met the criteria for inclusion. OCT analysis identified 2 characteristic morphologies following transretinal biopsy -a choroidal plugging of biopsy site (47.0%), or a flat retinal hole (53.0%). Choroidal plugging morphologies tend to remain unchanged over time, whereas flat holes demonstrate greater variability and would more commonly seal over with atrophic retina (Fisher Exact Value = <0.01). 60.8% demonstrated vitreous plugging of the biopsy site.
Conclusion: OCT analysis has identified key morphological changes following transretinal choroidal melanoma biopsy. The morphologies identified may provide dynamic protective effects against vitreous flow into the subretinal space, accounting for low rates of retinal detachment despite the presence of an untreated iatrogenic retinal hole following transretinal biopsy.
© 2022. Crown.
Conflict of interest statement
The authors declare no competing interests.
Figures




References
-
- Angi M, Kalirai H, Taktak A, Hussain R, Groenewald C, Damato BE, et al. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach. Br J Ophthalmol. 2017;101. 10.1136/bjophthalmol-2017-310361. - PubMed
-
- Grewal DS, Cummings TJ, Mruthyunjaya P. Outcomes of 27-Gauge vitrectomy-assisted choroidal and subretinal biopsy. Ophthalmic Surg Lasers Imaging Retina. 2017;48. 10.3928/23258160-20170428-07. - PubMed
-
- Grixti A, Angi M, Damato BE, Jmor F, Konstantinidis L, Groenewald C, et al. Vitreoretinal surgery for complications of choroidal tumor biopsy. Ophthalmology. 2014;121. 10.1016/j.ophtha.2014.06.029. - PubMed
-
- Reddy DM, Mason LB, Mason JO, Crosson JN, Yunker JJ. Vitrectomy and vitrector port needle biopsy of choroidal melanoma for gene expression profile testing immediately before brachytherapy. Ophthalmology. 2017;124. 10.1016/j.ophtha.2017.03.053. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous